Brian Miller is a Psychiatry physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5555 Grossmont Center Dr
Dept Of Behav Health
La Mesa, CA 919423019
Telephone
858-939-4393Registry record last updated 28 Feb 2017.
Clinical trials
- A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy
Sponsor: Sentien Biotechnologies, Inc.
- An Open-Label Trial of Tocilizumab in Schizophrenia
Sponsor: Brian Miller
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alkermes, Inc.Program year202526 payments$18,572openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202513 payments
- Neurocrine BioSciences, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
89.7%Atypical Antipsychotic43.1%Clozapine27%Olanzapine20%Quetiapine Fumarate13%Lurasidone Hcl8%Olanzapine Odt5%Invega Sustenna4%Aripiprazole4%Paliperidone Er4%Risperidone3%Lybalvi3%Fanapt2%Ziprasidone Hcl2%Uzedy1%Clozapine Odt1%Vraylar1%Asenapine Maleate1%Part D<11 patientsSSRI7.3%Trazodone Hcl42%Sertraline Hcl30%Fluoxetine Hcl15%Escitalopram Oxalate14%Part D<11 patients+ 21 more classes in this area
Cardiovascular
4.7%Beta blocker3.3%Propranolol Hcl64%Metoprolol Succinate29%Metoprolol Tartrate8%Part D<11 patientsStatin0.6%Atorvastatin Calcium100%Part D<11 patients+ 2 more classes in this area
Respiratory
2.1%Anticholinergic1.1%Glycopyrrolate100%Part D<11 patientsHistamine-1 Receptor Antagonist0.7%Diphenhydramine Hcl100%Part D≥27 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2006–2007 per NIH RePORTER. The latest:
- Temporal Dynamics of Top-Down Control Mechanisms in Memory
University of California Berkeley
FY2007$30,043F31MH075277 - Temporal Dynamics of Top-Down Control Mechanisms in Memory
University of California Berkeley
FY2006$30,043F31MH075277
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”